Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Clinical Research Ventures is a global venture capital firm founded to support life sciences companies in funding their clinical trials for pharmaceuticals, diagnostics, and medical technologies. With offices in Boston and Europe, the firm operates worldwide and has a portfolio of four notable companies. They focus on investments from seed through growth equity stages.
CR Ventures invests exclusively in companies conducting clinical trials in the life sciences sector, providing up to $50 million annually for trial costs. Their investment strategy emphasizes partnerships with clinical research organizations to ensure rapid start-up, enrollment, and successful trial completion. The firm does not invest in purely pre-clinical rounds.
Notable portfolio companies include Astrocyte Pharmaceuticals, Inc., which focuses on traumatic brain injury, stroke, and concussion; BioVersys AG, working on multi-drug resistant bacterial infections; Xeno Biosciences Inc., addressing obesity and related diseases; and Adiposs SA, concentrating on the early detection of cancer cachexia.
Email contactus@cr-ventures.com with your deck to pitch Clinical Research Ventures.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.